Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cerecor stock

Learn how to easily invest in Cerecor stock.

Cerecor Inc is a biotechnology business based in the US. Cerecor shares (CERC) are listed on the NASDAQ and all prices are listed in US Dollars. Cerecor employs 30 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Cerecor

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CERC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cerecor stock price (NASDAQ: CERC)

Use our graph to track the performance of CERC stocks over time.

Cerecor shares at a glance

Information last updated 2021-12-26.
52-week range$2.03 - $4.50
50-day moving average $2.88
200-day moving average $3.01
Wall St. target price$6.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.87

Buy Cerecor shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cerecor stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cerecor price performance over time

Historical closes compared with the close of $N/A from 2021-11-26

1 week (2022-01-18) N/A
1 month (2021-12-25) N/A
3 months (2021-10-25) N/A
6 months (2021-07-29) -100.00%
1 year (2021-01-29) -100.00%
2 years (2020-01-29) -100.00%
3 years (2019-01-29) -100.00%
5 years (2017-01-27) -100.00%

Cerecor financials

Revenue TTM $6.4 million
Gross profit TTM $-18,536,584
Return on assets TTM -72.52%
Return on equity TTM -213.81%
Profit margin 0%
Book value $0.23
Market capitalisation $285 million

TTM: trailing 12 months

Cerecor share dividends

We're not expecting Cerecor to pay a dividend over the next 12 months.

Cerecor share price volatility

Over the last 12 months, Cerecor's shares have ranged in value from as little as $2.03 up to $4.5. A popular way to gauge a stock's volatility is its "beta".

CERC.US volatility(beta: 1.44)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cerecor's is 1.4406. This would suggest that Cerecor's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cerecor overview

Cerecor Inc. , a biopharmaceutical company, focuses on development and commercialization of treatments for rare and orphan diseases. The company develops monosaccharide therapies for the treatment of congenital disorders of glycosylation, such as CERC-801, CERC-802, and CERC-803. It is also involved in the developing of CERC-007, an anti-IL-18 monoclonal antibody for the treatment of adult onset stills disease and multiple myeloma, as well as for the treatment of systemic juvenile idiopathic arthritis; CERC-006, an oral mTORC1/2 inhibitor to treat complex lymphatic malformations; and CERC-002, an anti-LIGHT monoclonal antibody that is in phase 2 clinical trial for the treatment of COVID-19 acute respiratory distress syndrome, as well as for the treatment of pediatric-onset Crohn's diseases. In addition, the company offers Millipred, an oral prednisolone for the treatment of inflammatory conditions, such as arthritis, blood disorders, immune system disorders, skin and eye conditions, respiratory disorders, cancer, and severe allergies. Cerecor Inc. has a collaboration agreement with The Frontiers in Congenital Disorders of Glycosylation Consortium on pivotal trial of CERC-801 for the treatment of Phosphoglucomutase-1 deficiency related congenital disorders of glycosylation.

Cerecor in the news

There are no recent company news

Frequently asked questions

What percentage of Cerecor is owned by insiders or institutions?
Currently 0.79% of Cerecor shares are held by insiders and 70.39% by institutions.
How many people work for Cerecor?
Latest data suggests 30 work at Cerecor.
When does the fiscal year end for Cerecor?
Cerecor's fiscal year ends in December.
Where is Cerecor based?
Cerecor's address is: 540 Gaither Road, Rockville, MD, United States, 20850
What is Cerecor's ISIN number?
Cerecor's international securities identification number is: US05338F1084
What is Cerecor's CUSIP number?
Cerecor's Committee on Uniform Securities Identification Procedures number is: 15671L109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site